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ARTICLE OPEN
Glutamine-to-glutamate ratio in the nucleus accumbens
predicts effort-based motivated performance in humans
Alina Strasser1, Gediminas Luksys2,3, Lijing Xin4, Mathias Pessiglione5, Rolf Gruetter6,7,8 and Carmen Sandi 1
Substantial evidence implicates the nucleus accumbens in motivated performance, but very little is known about the
neurochemical underpinnings of individual differences in motivation. Here, we applied 1H magnetic resonance spectroscopy
(1H-MRS) at ultra-high-field in the nucleus accumbens and inquired whether levels of glutamate (Glu), glutamine (Gln), GABA or
their ratios predict interindividual differences in effort-based motivated task performance. Given the incentive value of social
competition, we also examined differences in performance under self-motivated or competition settings. Our results indicate that
higher accumbal Gln-to-Glu ratio predicts better overall performance and reduced effort perception. As performance is the
outcome of multiple cognitive, motor and physiological processes, we applied computational modeling to estimate best-fitting
individual parameters related to specific processes modeled with utility, effort and performance functions. This model-based
analysis revealed that accumbal Gln-to-Glu ratio specifically relates to stamina; i.e., the capacity to maintain performance over long
periods. It also indicated that competition boosts performance from task onset, particularly for low Gln-to-Glu individuals. In
conclusion, our findings provide novel insights implicating accumbal Gln and Glu balance on the prediction of specific
computational components of motivated performance. This approach and findings can help developing therapeutic strategies
based on targeting metabolism to ameliorate deficits in effort engagement.
Neuropsychopharmacology (2020) 45:2048–2057; https://doi.org/10.1038/s41386-020-0760-6
INTRODUCTION
There are substantial individual differences in human achievement
in various life domains, from education to work or sports [1, 2].
Motivation is key to success and an important factor for goal-
directed behavior and well-being [3, 4]. Motivational deficits, such
as apathy, are prevalent in neurodegeneration and psychiatric
disorders [5–7]. Understanding the neurobiological underpinnings
that lead to individual differences in motivated performance can
help developing new strategies to ameliorate deficits in reward
valuation and effort engagement.
In agreement with the rodent literature [8, 9], the ventral
striatum, including the nucleus accumbens, has emerged in
humans as a key component of the motivation brain circuitry
regulating motivated behavior [10–14]. In addition to reward
processing, the nucleus accumbens has been implicated in cost-
based behavioral allocation for both mental and physical effort
[13]. However, knowledge about neurochemical mechanisms
linking accumbal function with motivated behavior is scarce.
Recently, the quantification of metabolites related to excitatory
[i.e., glutamate (Glu)] and inhibitory (i.e., GABA) neurotransmission
with 1H magnetic resonance spectroscopy (1H-MRS) has been
applied to predict individual differences in memory and decision-
making tasks [15–18]. Here, we targeted the nucleus accumbens
with 1H-MRS at ultra-high-field (7 T), allowing a precise quantifica-
tion of Glu and GABA, and the effective separation of Glu and its
metabolic precursor glutamine (Gln) [19] to predict effort-based
motivated performance. Importantly, motivated performance is a
complex process that involves multiple behavioral functions [1, 8].
Our aim was to investigate whether resting levels of Glu, Gln,
and GABA, and Gln/Glu and GABA/Gln ratios predict specific
components of effort-based motivated performance. To
provide evidence for the accumbal specificity of these
neurochemical–behavioral associations, we also performed 1H-
MRS in the occipital lobe. Importantly, in addition to their role in
neurotransmission, these three metabolites participate in multiple
metabolic pathways, including energy production and the
synthesis of the antioxidant glutathione [20].
To dissect motivation into its component elements, we used a
recently developed effort-based monetary incentivized task [21]
that combines aspects from the MID task [10] and effort-based
decision-making paradigms [11, 22]. Importantly, this task probes
different aspects of motivated performance while capturing a
wide range of individual differences [21]. In addition, in order to
account for the modulation of performance by situational factors
[23, 24], and given the capacity of social competition to improve
performance in a variety of settings [25–28], we compared
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performance under competition versus self-motivated
performance.
Then, we applied computational modeling designed to dissect
performance in this task to specific components such as curvature
of the utility function, sprint and endurance stamina, performance
baseline and its randomness. Previous studies [29–32] have shown
that computational approaches enhance our insight to behavioral
mechanisms and reveal otherwise inaccessible neurobiological
correlates. Here, applying computational modeling allowed us to
reveal critical associations between metabolites, or their
ratios, and particular components underlying motivated perfor-
mance (e.g., utility curvature, stamina, and other performance
parameters). We show that the accumbal ratio of glutamine-to-
glutamate specifically predicts effortful performance, by particu-
larly relating to the stamina required to keep up performance
throughout the task.
MATERIALS AND METHODS
For complete information on Materials and Methods, please see
Supplementary Methods
Participants
From 43 men, 20–30 years old, originally recruited for the study,
we obtained valid MRS data from 27 of them (i.e., data from 16
participants could not be fully collected and included in the
analysis; see specific reasons in Participants section in Supplemen-
tary Methods). Participants were characterized for several person-
ality measurements (see section on Personality questionnaires and
anthropometric characteristics in Supplementary Methods). Data
analyzed here is part of a larger study from which a report on the
link of metabolites with anxiety trait has been previously
published [33]. Informed consent was obtained from all partici-
pants in the study. Experiments were performed in accordance
with the Declaration of Helsinki and approved by the Cantonal
Ethics Committee of Vaud, Switzerland. See Supplementary
Methods for further details.
Proton magnetic resonance spectroscopy (1H MRS) acquisition
and data processing
The MR measurements were performed on a Magnetom 7 T/68-
cm head scanner (Siemens, Erlangen, Germany) equipped with a
single-channel quadrature transmit and a 32-channel receive coil
(Nova Medical Inc., MA, USA). The NAc region of interest voxel
(VOI) was defined by the third ventricle medially, the subcallosal
area inferiorly, and the body of the caudate nucleus and the
putamen laterally and superiorly, in line with definitions of NAc
anatomy identifiable on MRIs [34] (Supplementary Fig. 1). A
representative spectrum of the NAc voxel is shown in Fig. 1a. We
obtained an overall spectral SNR and linewidth of 72 ± 9 and
0.048 ± 0.006 ppm, respectively. Glu, Gln, and GABA concentra-
tions in the NAc were quantified with CRLB of 2.36 ± 0.49%, 4.91 ±
0.75% and 11.32 ± 2.78% (Supplementary Table 2). Given that, in
order to obtain high-quality MRS measurements in the NAc in the
7 T requires 90min of scanning time, MRS acquisition in a second,
control brain region had to be postponed to a subsequent session.
Thus, we obtained spectra from the occipital lobe as an
experimental control on 17 participants that were successfully
recruited for a second scanner. See Supplementary Methods for
further details.
Effort-related monetary incentive force task
Our modified monetary incentive delay (MID) task [10] version [21]
relied on exerting force on a hand grip or dynamometer
(TSD121B-MRI, Biopac) (Fig. 1d) at a threshold corresponding to
50% of each participant’s maximum voluntary contraction (MVC)
and, therefore, was termed monetary incentive force (MIF) task. To
investigate the influence of competition on performance, the
experiment was run under two experimental conditions, an
isolation and a competition condition. Success rate was computed
in % of successful trials out of total trials, and for each of the four
sessions (i.e., SuccessTotal, SuccessSession 1, SuccessSession 2, Suc-
cessSession 3, and SuccessSession 4) and for each of the three
incentives (i.e., CHF 0.2, 0.5, and 1). See Supplementary Methods
for further details.
Computational modeling
To study more intricate aspects of motivated performance, we
developed a computational model thereof. As described above,
participants had to reach the same threshold for successful
performance with different incentives (CHF 0.2, 0.5, and 1), and
their performance was energetically costly since force had to be
exerted. Hence, at each trial, subjects were primed with different
monetary incentive values and they subsequently had to decide
whether to invest energy in this trial and to perform the task
accordingly. To build our model, we consequently assumed that (i)
metabolic resources gradually decline during the task along with
the cumulative effort exerted by participants and that (ii) a certain
degree of metabolic recovery will take place during the 3min
resting break that participants were given between the two task
blocks. We termed these two components participants’ sprint
stamina (εspr) and endurance stamina (εend): εspr quantified the
fraction of initial energy remaining at the beginning of session 2 of
each of the two blocks and εend quantified the fraction of initial
energy remaining at the beginning of session 3 (i.e., after the 3
min break) to account for recovery experienced during the break.
Subjective utility (i.e., how nominal value relates to perceived
value) was modeled using a difference of a common power law
function [35] for reward gains and effort costs [36] as
u xð Þ ¼ xα  τ; (1)
where xα is the reward gain component and τ the effort cost
component. For the reward gain component, x is monetary value
(CHF 0.2, 0.5, and 1) and parameter α (utility curvature) describes
how much participants valued high versus low incentives. Values
of α under 1 reflected concave utility, which is very common in
behavioral economics. For the effort cost component, participants’
average energy level during a session was modeled using function
E with E= 1 during session 1 (referring to the initial amount of
energy) and E= εspr, E= εend, and E= εspr*εend during sessions
2–4, respectively (with 0 < εspr < 1 and 0 < εend < 1, as energy was
expended during continuous performance but partially recovered
during the break). Then the effort component τ consisted of effort
cost baseline b and energy loss 1− E:
τ ¼ bþ 2ð1 EÞ: (2)
Consequently, τ was equal to b when the participant had full
energy and b+ 1 when E= 0.5. It might seem appropriate to have
included another parameter bmax instead of 2 (a constant) to
define an upper limit to τ, but as monetary values could also be
adjusted arbitrarily on the gain side (e.g., 20/50/100 instead of 0.2/
0.5/1) to counter its effect, having arbitrary scaling of τ (and an
extra free parameter) was unnecessary, as free parameters of the
effort cost function (b, εspr, and εend) provided sufficient flexibility.
We modeled probability of success in a trial (reaching the
necessary force threshold and maintaining it for 3 s) using a
sigmoidal function of subjective utility u(x) and sigmoidal
steepness (inverse temperature) β, which determined choice
randomness (higher β= less randomness)
PðsuccessÞ ¼ 1
1þ euβ : (3)
Our model is similar to Le Bouc et al. [36], with the main
differences being that our model uses utility curvature for
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rewards (common in behavioral economics), our effort
cost baseline b is related to effort sensitivity divided by
reward sensitivity in Le Bouc et al. [36], and 1− E (energy loss)
to susceptibility to fatigue/fatiguability there. We modeled
loss of energy exponentially as opposed to linearly, as it
may be a better approximation. Because of the nature
of our data, we also used discrete points (averages of four
sessions) instead of continuous time. Hence, our stamina
parameters are closely linked to fatiguability parameter Kf in
Le Bouc et al. [36].
Residual 
 NAc 1H spectrum
LCModel Fit
Glu
Gln
GABA
Macromolecules
Baseline
Glu
Gln
Glu
Gln G
A
B
A
ppm
4 3.5 3 2.5 2 1.5 1 0.5
Glutamine-to-glutamate ratio in the nucleus accumbens predicts. . .
A Strasser et al.
2050
Neuropsychopharmacology (2020) 45:2048 – 2057
Twelve performance measures (PMs) were chosen: success rates
in each of the 4 sessions and for each of the 3 incentives. To
evaluate how well the model fits participants’ performance, a
goodness of fit function was used [29, 30] where PM1–PM12 are 12
PMs for experimental data (exp) and where modeled performance
(mod) was based on the parameters (α, β, εspr, εend, and b) per
individual, and σexpi
 2
was the variance in the experimental data
of PMi.
A Monte Carlo-like stochastic search was used for parameter
estimation. Our approach ensured that our search explored the
parameter space sufficiently, whilst also leading to considerably
accurate and reliable parameter values (see Supplementary
Methods for more details on parameter generation distributions
for the estimation of different model parameters).
RESULTS
Following participants’ recruitment and random allocation to one
of the two experimental conditions (i.e., performance in either
isolation or competition; see Supplementary Methods), we verified
that the two groups did not differ for key personality traits (i.e.,
trait anxiety, dominance motivation, competitiveness, self-
perceived social rank, and trait physical fatigue), states (i.e., state
anxiety and state physical fatigue) or other anthropomorphic
characteristics (Supplementary Table 1). The two groups were also
equivalent for their levels of physical activity or body mass index,
and had similar levels of hand-grip maximal voluntary contraction
(MVC) (Supplementary Table 1).
Glutamate, glutamine, and GABA levels in the nucleus accumbens
We applied 1H-MRS to measure metabolite concentrations in the
NAc (Fig. 1a; Supplementary Fig. 1). Enhanced spectral resolution,
due to performing the neurochemical profiling at 7 T, led to more
reliable measurements of J-coupled metabolites, such as Gln, Glu,
and GABA, than achievable with 1H MRS at lower magnetic fields.
Our approach reliably distinguished the methylene groups of Glu
and Gln at 2.34 and 2.44 ppm (Fig. 1a). The concentration of
metabolites of interest (Glu, Gln, and GABA) and their ratios (Gln/
Glu and GABA/Gln) are reported in Fig. 1b and did not differ a
priori between experimental groups (Supplementary Table 2). As
expected, we found that total accumbal Glu and Gln—and
consequently Gln and the Gln/Glu ratio—were highly correlated
(Supplementary Table 3). Moderate correlations between Glu and
Gln, on the one hand, and GABA were also observed (Supple-
mentary Table 3).
Competitive context and incentive size enhance task performance
Following 1H-MRS acquisition, participants were given the
opportunity to work toward different monetary reward levels by
squeezing a handgrip at 50% of their MVC (Fig. 1c, d). Given that
the neurochemical data from 1H-MRS is not time resolved (i.e., a
baseline or resting state measurement is taken just before task
performance), effort requirements (i.e., handgrip force) were
maintained constant across different incentives. This allows
assessing performance depending on incentive level without the
confounding of divergent effort exertion across participants that is
inherent to effort-based decision-making paradigms [1]. The
ability to maintain responses over time is a fundamental feature
of motivational processes [22], while fatigue from effort exertion
tends to impair endurance performance. Accordingly, our task is
quite demanding, involving 80 trials distributed across 4 sessions
of 20 trials each, enabling to address performance dynamics with
time. Moreover, given the importance of breaks for effortful
performance [37] we introduced a 3-min break between sessions
2 and 3 to assess individual’s capacity to recover from rest. Finally,
we compared performance under competition (n= 12) versus self-
motivated performance (n= 15). For participants in the former
group, the monetary gain depended on whether participants’
performance was better or worse than that of a “given”
competitor.
Our results indicated that performance was influenced by
both social context (F(1, 75)= 13.91; p= 0.0004) and incentive size
(F(2, 75)= 12.23; p < 0.0001). Thus, competitive context enhanced
success rate, and so did incentive size (Fig. 1e; for full data by
session and incentive, see Supplementary Fig. 2). There was no
interaction between social context and session number (p= 0.827;
Fig. 1f).
NAc glutamine relates to better performance and reduced effort
perception
Before dissecting general performance into its components with
computational modeling, we carried out a first set of correlational
analyses on all participants (Fig. 2a). We found positive correla-
tions between Gln and Gln/Glu, respectively, and success rate
(Fig. 2b, c), while negative correlations between Gln and Gln/Glu,
respectively, and effort perception (Fig. 2d, e).
Computational modeling
We applied computational modeling (see Supplementary Methods
for more information) to reveal more intricate components of task
performance and, subsequently, to study their relation to the
Fig. 1 In vivo 1H MR spectroscopy in the nucleus accumbens at rest and experimental design of behavioral testing. a This panel includes a
representative 1H MR spectrum acquired with the semi-adiabatic SPECIAL sequence at 7 T (TE/TR= 16ms/6500 ms, 256 averages), as well as
the corresponding LCModel spectral fit, fit residual, macromolecules, baseline and individual metabolite fits for glutamate (Glu), glutamine
(Gln), and GABA. b Accumbal metabolite concentrations for glutamate, glutamine, and GABA. No differences in metabolite concentrations
were observed between the experimental groups (two-sided independent Student’s t test), indicating optimal group matching for these
metabolite concentrations. No differences in metabolite concentrations were expected between the experimental groups (i.e., between
isolation and competition) at baseline, as MRS acquisition took place before the social manipulation. Mean metabolite concentrations for both
groups combined are also shown (marked Total in the gray bar). Glu glutamate, Gln glutamine, GABA gamma-aminobutyric acid. Error bars are
shown in standard deviations. c Modified incentive delay task and the performance of the different participants in the isolation and
competition context. Visual stimuli of the modified monetary incentive delay task in the CHF 1 isolation condition. In the competition
condition, the gray plus sign was replaced with a gray cartoon of a male opponent, overlaid by the text “against 1”. Successive screen images
were shown to participants whilst they were performing the hand grip task, and which guided and cued their performance in line with the
instructions that were received prior to data acquisition. We ensured that all participants had seen all visual stimuli and understood the task
during the 20-trial experimental practice session. d Exemplary trial dynamic. Here, we show the force dynamics that would occur after the 3 s
anticipation period shown in (c). The anticipation period was always followed by a 2 s period during which the force threshold of 50% of their
maximal voluntary contraction (MVC) had to be reached. Then, participants had to maintain the force at their threshold level for another 3 s. If
successful in this, a green tick appeared on the screen for 1 s, if not, a red cross. e This plot shows the success rate of each participant
(indicated as a dot), in the isolation and the competition condition. Performance is shown as a function of the three different incentive sizes
(CHF 0.2, CHF 0.5, CHF 1) and of the isolation and competition contexts. In f participants’ performance is plotted as a function of session
number (1–4) and of the isolation and competition contexts. The task was structured into two blocks, separated by a 3min break. Each block
contained 2 sessions of each 20 trials: 5 rest trials that occurred at an interval of every 3 action trials, with the incentive sizes varying
pseudorandomly to ensure that each incentive could be earned 5 times. The entire MIF task comprised 80 trials. Error bars, SEM. n= 15;
isolation. n= 12, competition.
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measured NAc metabolite (i.e., Glu, Gln, and GABA) concentrations
and their ratios, as well as performance within experimental
groups.
Parameter estimation and model comparison
Briefly, our model consisted of parameters related to utility
curvature (α, controlling subjective perception of incentive sizes),
effort cost (baseline b and stamina parameters indicating
increased effort cost due to fatigue) and performance function
(with steepness β of the sigmoidal relationship between outcome
utility and success rate). Effort cost baseline b was indicative of
overall initial performance, with lower values denoting better
performance. Stamina function controlled the loss of energy due
to fatigue: sprint stamina (εspr) over adjacent sessions (i.e., 2 versus
1 and 4 versus 3), and endurance stamina (εend) over the two
blocks of the experiment, that were separated by a 3min break.
The stamina functions in our model is a variation from a generic
fatiguability function used in other models (e.g., [36]; also see
Methods), using two parameters to approximate its rate and
recovery during the break. We compared it to a more standard
single parameter-based formalization, which performed worse.
First, we addressed the contribution of each parameter to
performance success throughout the four sessions in the task
and for the three different incentives (CHF 0.2, 0.5, and 1). Model
simulation results where each parameter is varied separately
(Supplementary Fig. 3) show a variety of nonlinear effects that
arise due to a sigmoidal relationship between utility and success
rate: differences in effort cost baseline (b) lead to the largest
variability in performance, whereas other parameters have more
nuanced effects, limited to certain incentives or experimental
sessions.
First, we verified that five parameters were an appropriate
model size, capturing the dynamics in individuals’ task perfor-
mance. For this, we characterized participants’ behavior in the
incentive delay task by twelve PMs, relating to the success rates in
the different sessions (1–4) and for the different incentive sizes
(CHF 0.2, 0.5, and 1). Because these success rates were correlated
among each other, we performed a principal component analysis
(PCA) to determine the effective dimensionality for the twelve
success rate performance measures. The PCA revealed compo-
nents with gradually decreasing eigenvalues, where the first 5
components explained 85% of the variance (Supplementary
Table 4). Although 15% of the variance remained unexplained, it
suggested that a model with 5 parameters would be sufficiently
flexible to fit performance success adequately. A χ2 test with v=
12− 5= 7 degrees of freedom evaluated the goodness of
the parameter estimation. Goodness-of-fit error was lower
than χ27, 0.05= 14.07 for every participant, suggesting that the
difference between model fit and experimental data was not
significant (p > 0.05), hence the model was able to approximate
individual performance with a best fitting set of parameters
for each participant. Mean goodness of fit error was χ2= 3.55 with
p= 0.83, indicating an excellent fit. Spearman correlation
coefficients between the top 4000 estimated parameter sets for
each parameter ranged between 0.97 and 0.98, which
indicated that our stochastic parameter estimation procedure
was stable and reliable. For this reason, applying the best fitting
parameter set in statistical analyses seemed appropriate. We also
performed parameter recovery analysis by generating perfor-
mance measures based on model with known parameters
and estimating them using the same procedure. Newly estimated
and original parameters were highly correlated with each
other: Spearman ρ(α)= 0.963, ρ(β)= 0.956, ρ(b)= 0.979, ρ(εspr)=
0.981, ρ(εend)= 0.995, indicating high reliability of parameter
recovery.
We then compared our model with a simpler formalization of
fatiguability, that has a single rate for energy loss (e.g., εspr). This
corresponds to εend= εspr
2 in our model, in which case energy
levels in 4 sessions are proportional to 1, εspr, εspr
2, and εspr
3. We
performed the identical parameter estimation procedure for this
model as for the original model and found that its mean
goodness-of-fit χ2= 4.343 was significantly worse than of the
initial model (paired t test p= 0.048), which remained true even if
smaller number of parameters was considered—4.343 corre-
sponded to p= 0.82 of χ2 distribution with v= 12− 4= 8 degrees
of freedom. Hence, we decided to keep the more flexible model.
Fig. 2 Bivariate correlations between Glu, Gln, GABA, Gln/Glu, and GABA/Gln and total success rate plotted for both groups (isolation
and competition) combined. a Correlation matrix of Glu, Gln, GABA, Gln/Glu, GABA/Gln with performance and effort perception. b NAc
glutamine plotted against performance. c NAc Gln/Glu plotted against performance. d NAc glutamine plotted against effort perception. e NAc
Gln/Glu plotted against effort perception. Glu glutamate, Gln glutamine, GABA gamma-aminobutyric acid, NAc nucleus accumbens. Success
rate was quantified in percentage of correct trials. Effort perception was defined as the level of subjects’ perceived MVC threshold necessary
for successful trial completion as described in “Methods”. *p < 0.05. All correlation coefficients are Pearson’s, unless indicated otherwise
(Spearman’s; S). n= 22.
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Performance parameters in the isolation and competition groups
We then compared performance parameters between the
experimental groups. Participants’ utility curvature (α), sprint
stamina (εspr), and endurance stamina (εend) were not normally
distributed, whereas those of sigmoidal steepness (β) and effort
cost baseline (b) were (Table 1).
Participants in the competition group had a substantially
lower effort cost baseline (b) than in the isolation group (Table 1,
two sample t test, t= 4.00, p= 0.00049), indicating higher initial
performance success in the competition context. Furthermore,
participants in the isolation group exhibited higher sprint
stamina than in the competition group (Table 1, Mann–Whitney
U test, ranksum= 255, p= 0.0284), suggesting that the compe-
tition context resulted in fatigue quicker than the isolation
context.
Correlations between parameters (Supplementary Table 5) were
low to moderate, with only sprint and endurance staminas (εspr
and εend) showing high correlation, indicating partially over-
lapping neurobehavioral mechanisms. We also tried to fix values
of one of these parameters to their average population value and
estimated the remaining parameters to see if model fit could be
improved (considering lower model complexity). However, with
one parameter fixed these models performed considerably
worse than the initial model, mean χ2 (with εend fixed)= 4.82=
χ28, 0.78 (paired t test P= 0.020) and χ
2 (with εspr fixed)= 4.67=
χ28, 0.79 (P= 0.021), suggesting that despite high correlation
between them, keeping both parameters flexible was essential for
the best fit.
Given that anxiety can affect competitive confidence and
motivated performance [21, 38], we examined whether anxiety
trait is related to the model parameters. We computed associa-
tions with measures of state and trait anxiety, and found none of
them to be significant (Supplementary Table 6).
Performance parameters and Gln/Glu ratios
As Gln/Glu concentration ratio was the most strongly correlated
with both performance and effort perception (Fig. 2), we
examined associations between Gln/Glu and estimated model
parameters in order to explore neurochemical correlates of
specific components underlying motivated performance (note,
however, that associations with all metabolites are provided for
reference in Supplementary Table 7). We then performed multiple
linear regression with the metabolite concentration ratio and
experimental group (i.e., isolation versus competition) as the
independent variables and model parameter as the dependent
variable. For model parameters that were not normally distributed,
rank regression was used. These analyses revealed that Gln/Glu
predicted participants’ endurance stamina εend (p= 0.003, Table 2)
and to a lesser extent their sprint stamina εspr (p= 0.010, Table 2).
No statistically significant associations were found between Gln/
Glu in the occipital lobe and any of the model parameters
(Supplementary Table 8).
We then tested whether differences in average task success rate
as well as in model parameters associated with the social context
(effort cost baseline b and sprint stamina εspr) were mediated by
Gln/Glu concentration ratios. For this purpose, we divided
participants into those having below versus above average Gln/
Glu values and performed a two-way ANOVA with interactions (for
not normally distributed εspr using ranks) to study how social
context (i.e., isolation versus competition) and Gln/Glu concentra-
tion ratios interact in influencing task success rate and perfor-
mance parameters. We also performed multiple linear regression
(for not normally distributed εspr using ranks) with the metabolite
concentration ratio, social context (i.e., isolation versus competi-
tion) and multiplicative interaction between them (with social
context coded −1/1) as the independent variables and task
success rate, parameters b and εspr as the dependent variables
(Supplementary Fig. 4).
We found that overall performance (Fig. 3a) was significantly
related to both the social context (F1,21= 9.3, p= 0.007) and Gln/
Glu group (F1,21= 5.7, p= 0.028), with both competition and high
Gln/Glu predicting better performance. For effort cost baseline b
(Fig. 3b), we observed both a significant effect of the social
context (F1,21= 5.7, p= 0.029) and a significant interaction with
Gln/Glu group (i.e., high or low) (F1,21= 4.5, p= 0.048). Further
inspection revealed that competition only led to lower b values
(hence boosted initial performance) in participants with low Gln/
Glu values (two sample t test df= 11, t= 3.1, p= 0.011), but had
no effect on participants with high Gln/Glu ratios (df= 7, t= 0.28,
p= 0.79). For sprint stamina εspr (Fig. 3c), there were no significant
group effects for the social context (F1,21= 3.0, p= 0.098) or Gln/
Glu group (F1,21= 2.8, p= 0.11) in ANOVA but a significant
positive correlation with Gln/Glu in the regression model
Table 1. Comparison of performance parameters between the
isolation and competition groups.
Parameter Normality
based on
total sample
Group M/median; SD/
IQR
Test
statistic
and
p value
α (utility
curvature)
p < 0.0001 Isolation Median= 0.288
IQR= 1.55
Ranksum
= 231
p= 0.317Competition Median= 0.102
IQR= 0.688
β (sigmoidal
steepness)
p= 0.35 Isolation M= 16.1
SD= 13.9
t= 1.89
p= 0.0697
Competition M= 7.5
SD= 8.0
b (effort cost
baseline)
p= 0.53 Isolation M= 0.356
SD= 0.535
t= 4.00
p=
0.00049Competition M=−0.813
SD= 0.962
εspr (sprint
stamina)
p= 0.0032 Isolation Median= 0.969
IQR= 0.061
Ranksum
= 255
p= 0.0284Competition Median= 0.621
IQR= 0.87
εend
(endurance
stamina)
p= 0.013 Isolation Median= 0.998
IQR= 0.055
Ranksum
= 231.5
p= 0.284Competition Median= 0.941
IQR= 0.408
Normality was computed with the Kolmogorov–Smirnov test. M mean, SD
standard deviation, IQR interquartile range. Comparisons were computed
with Student’s t test for normally distributed parameters and with the
Mann–Whitney U test for not normally distributed parameters.
Table 2. Multiple linear regression results (p values) with nucleus
accumbens Gln/Glu concentration ratios and experimental task
framing as independent variables and estimated model parameter as
the dependent variable.
Model parameter Association with Gln/
Glu (p values)
Association with task
framing (p values)
α (utility curvature) 0.13 (0.046)
β (sigmoidal
steepness)
0.29 (0.096)
b (threshold baseline) 0.26 (0.008)
εspr (sprint stamina) 0.010 (0.045)
εend (endurance
stamina)
0.003 (0.29)
For negative associations p values are shown in parentheses.
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(Supplementary Fig. 4). We also found a significant difference
between low Gln/Glu group under the competition condition and
high Gln/Glu group under the isolation condition (Wilcoxon rank
sum test p= 0.047, ranksum= 36). This suggests that participants
with low Gln/Glu ratio in the competition condition started out the
best (low effort cost baseline b), but their performance also
declined the fastest (low sprint stamina εspr).
DISCUSSION
The nucleus accumbens is part of the brain circuitry that
regulates effort-related motivated functions [7, 8, 13]. Here, we
investigated whether variation in NAc metabolite levels relate to
individual differences in motivated performance. We found that
accumbal Gln-to-Glu ratio at resting state predicts the overall
average performance in an effort-based motivated task.
Importantly, as motivated performance is quite multifaceted,
with its different components possibly related to Gln-to-Glu
ratio in different ways, we applied computational modeling to
deconstruct global performance into specific components. We
used a model with its parameters determining curvature of the
utility function, sprint and endurance stamina, effort cost
baseline and performance randomness, and then estimated
the best fitting parameters to each subject’s performance.
Subsequently, we inquired which performance components are
better predicted by accumbal metabolites. This approach
allowed us to relate individual differences in accumbal Gln-to-
Glu ratio specifically with variation in endurance stamina (εend,
the capacity to recover performance following a short rest-break
period) and—to a lesser extent—sprint stamina (εspr, a measure
of fatigability) displayed by participants subsequently, during
motivated performance.
The neurochemical profiling in this study benefitted from the
ability of increased spectral resolution at 7 T to reliably measure J-
coupled metabolites, such as Gln, Glu, and GABA separately. This is
an advantage over substantial prior work performed at ≤3 T that
due to limitations to separate Glu and Gln, frequently report Glx as
the compound measurement of these two metabolites. Glutamine
is synthesized from Glu in astrocytes in a reaction catalyzed by Gln
synthetase [39]. Once astrocytes release Gln, it can be taken up by
neurons where it is readily converted to Glu [39, 40] (in GABAergic
neurons, Glu is further converted into GABA [41]). Therefore,
obtaining the distinct measurement of Gln is very important as it
allows estimating the ratios between Gln and, respectively, Glu
and GABA, thus providing indices of neurotransmitter potential or
“reservoir”.
Our computational model-based analysis approach, which has
been successful in elucidating internal behavioral variables of
reward-based learning (such as learning rates [42],
exploration–explotation balance [30], discounting [43], episodic
memory [29], effort [14], mood [44], social [45], and economic
preferences [46, 47]), allowed us here to provide key insights into
the specific components of motivated performance that relate to
accumbal metabolites. We found that the Gln-to-Glu ratio is
positively linked to stamina necessary to maintain performance
over longer periods, whereas the competition context leads to
substantially improved initial performance accompanied by a
faster loss in stamina, and which was particularly pronounced in
individuals with low resting Gln-to-Glu levels. Importantly, our
data suggests that Gln rather than Glu or GABA is the main
contributor to the reported association between accumbal Gln-to-
Glu ratio and endurance stamina (εend).
Medium spiny neurons, the main neuronal type in the nucleus
accumbens comprising about 95% of accumbal cells, range from
GABAergic to mixed GABAergic and glutamatergic [48]. In
addition, the nucleus accumbens receives GABAergic and
glutamatergic projections from multiple brain regions [48, 49].
Therefore, Glu and GABA concentrations measured in the NAc
through 1H-MRS represent pools of both accumbal and afferent
neurons. Due to the more local nature of glial cells, Gln levels in
our data primarily represent production by accumbal glial cells
(including astrocytes and oligodendrocytes) [50, 51]. Therefore,
our findings point towards a key contribution of accumbal glial-
derived Gln, and particularly the Gln-to-Glu ratio, on effortful
endurance in motivated behavior.
It is important to note that, in addition to its role in
neurotransmitter production, Gln is also involved in mitochondrial
oxidative phosphorylation and, consequently, cellular energy pro-
duction [20, 52]. Therefore, high accumbal Gln levels (particularly
in situations of increased Gln-to-Glu ratio) can be regarded as a
multifunctional metabolic reservoir that, depending on cellular
requirements, can be readily utilized for neurotransmitter production
and/or fueling mitochondrial function [53, 54]. Accordingly, high Gln
concentrations might allow for enhanced GABA and Glu concentra-
tions to be achieved (via just-in-time synthesis) during task
performance [55], accommodating the behavioral requirements to
succeed. Indeed, our results suggest that performance is not
maintained via already present GABA or Glu pools, because neither
resting-state GABA nor Glu predicted endurance performance.
In addition, high Gln concentrations may contribute to fuel
mitochondrial function under enhanced NAc engagement during
motivated and effortful behaviors, which are recognized accumbal
putative actions [10, 13, 56, 57]. In support of this hypothesis, work
in rodents has shown that the capacity to remain on task for
longer and to overcome greater effort costs is related to the
magnitude of NAc oxygen responses to delivered rewards [58].
Oxygen consumption reflects mitochondrial respiration, a critical
mitochondrial function and partial proxy for energy production in
low Gln/Glu
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Fig. 3 Individual differences in task performance and model
parameters as a function of either low or high Gln/Glu ratio in the
NAc and social context. Interaction between Gln/Glu ratio and
social context (isolation versus competition group) in determining a
mean overall success rate, b effort cost baseline b, which is
indicative of initial task performance and c sprint stamina εspr,
indicative of performance decline over consecutive sessions. Social
context only influenced initial performance in participants with low
Gln/Glu ratio values, letting them achieve the best performance in
the competition condition, despite faster performance decline. Blue
bars: isolation; red bars: competition. *p < 0.05.
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the form of ATP. Strikingly, higher mitochondrial oxygen
respiratory capacity in the NAc in male rodents is positively
related to the capacity to win a social competition [59, 60].
Therefore, our results relating accumbal Gln-to-Glu ratio to the
capacity to exert motivated effort provide novel metabolic
insights to this body of data.
One of the mechanisms whereby Gln-to-Glu ratio may
contribute to differences in endurance and sprint stamina is the
capacity of individuals with a high Gln-to-Glu ratio to overcome
fatigue. Fatigue induced by prolonged active task engagement
can have a negative impact on endurance performance.
Performance decrements induced by fatigue have been proposed
to be due to perception of effort and can lead to task
disengagement or “giving up” [61]. In sports, for example, the
psychobiological model of endurance performance states that
effort perception plays a crucial role in explaining how fatigue
reduces the willingness to perform [62] and negatively affects
performance [61]. Recent accounts of human motivated perfor-
mance emphasize the perception of effort as a crucial factor
underlying motor endurance performance [63]. The inverse
relationship that we found between Gln-to-Glu levels and effort
perception may provide support for this account, especially in
light of our decomposition of motivated performance into an early
component that is boosted in low Gln-to-Glu individuals under
competition (as a sign of excessive effort) and the stamina
component, which is, subsequently, reduced in the same
individuals. Although, to the best of our knowledge, no previous
study assessed NAc metabolism in the context of fatigue,
substantial influence relates fatigue with reduced Gln in blood
[64] and potentially also with alterations in Gln metabolism in the
brain [65]. Oral glutamine supplementation has been reported to
reduce subjective fatigue and ratings of perceived exertion during
demanding tasks [66, 67] and to increase striatal Gln levels [68].
At the neurobiological level, several mechanisms may account
for the observed differences in Gln and Gln-to-Glu ratio, including
differences in Gln production, metabolite catabolism and the
availability of cellular transporters for Gln and Glu. The nucleus
accumbens has been implicated in anhedonia, reduced motiva-
tion, and decreased energy typically found in individuals with
depression [69] and substantial data indicate alterations in these
metabolic pathways and depression. For example, reduced
cortical density of glutamine synthetase-expressing astrocytes
has been found in post mortem brains of major depression
patients [50] and genetic variation in the gene coding for this
enzyme associated with depression [70]. In addition, reduced
levels in NAc Gln were reported in a rat model of stress-induced
depression [44].
We also found that performance in our task was enhanced by
social competition, in alignment with a reported facilitative role of
competition in task performance [25–28]. Our computational model
revealed that the facilitating effect of competition on the overall
performance was mostly due to improvement in initial performance
(expressed through lower values of effort cost baseline b), which
persisted despite lower values of sprint stamina (εspr, which
manifested itself in poorer performance in later task sessions).
Furthermore, we found a significant interaction between competition
context and Gln-to-Glu ratios in determining initial performance: the
initial performance boost triggered by social competition was only
observed for participants with a low Gln-to-Glu ratio. Participants
characterized by a high Gln-to-Glu ratio seemed to have superior task
engagement from the onset of the task, which was not significantly
boosted by competition. This observation suggests a link between
high accumbal Gln-to-Glu and self-motivated performance in
effortful incentivized challenges.
Finally, the associations between metabolites and performance
were not observed in the occipital lobe, in agreement with reports
indicating a lack of correspondence in Gln or Gln-to-Glu levels
across different brain regions [71]. However, a note of caution
should be added, as due to technical limitations, metabolites in
the occipital lobe were acquired on a different day in a subsample
of the participants. This implies that the power to detect a
significant behavior–metabolite association in the occipital lobe
was lower, and it would be important in future studies to verify
the specificity of the reported associations for the NAc. In this
study, only males were included as our prediction for a link
between accumbal metabolism and motivated performance was
inspired in background studies involving male rodents [59, 72, 73].
In addition, due to technical challenges mainly associated with
scanning at 7 T, our original participant recruitment was reduced
to a moderate sample size, which limits the generalization of the
obtained results. Therefore, future studies are warranted to test
whether our findings are generalized to the general population.
Finally, although our approach allowed us to reveal important
components of motivated performance, in the future it will be
important to disentangle further aspects such as effort-related
decision-making and vigor of response.
In conclusion, our results provide the first solid evidence for the
role of accumbal metabolites—particularly the Gln-to-Glu ratio—in
different components of effortful performance. We envision that this
approach and findings can help developing metabolism-targeting
strategies to ameliorate deficits in motivated effort engagement.
FUNDING AND DISCLOSURE
This work was supported by grants from the Swiss National
Science Foundation (CR20I3-146431; NCCR Synapsy grant number
51NF40-158776) and intramural funding from the EPFL. The
authors declare no competing interests. Open Access funding
provided by EPFL Lausanne.
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding
authors upon request.
CODE AVAILABILITY
The code used in this study is available from the corresponding authors upon
request.
ACKNOWLEDGEMENTS
We would like to thank Fiona Hollis for valuable discussions regarding the
experimental design.
AUTHOR CONTRIBUTIONS
AS and CS designed the study; AS and LX performed the experiments; GL designed
the computational model; MP contributed to the computational model. AS, LX, and
GL analyzed the data; RG supervised the MRS work. CS, AS, and GL wrote the paper
with contribution from all authors.
ADDITIONAL INFORMATION
Supplementary Information accompanies this paper at (https://doi.org/10.1038/
s41386-020-0760-6).
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional affiliations.
REFERENCES
1. Chong TT-J, Bonnelle V, Husain M. Quantifying motivation with effort-based deci-
sion-making paradigms in health and disease. Prog Brain Res. 2016;229:71–100.
2. Duckworth AL, Eichstaedt JC, Ungar LH. The mechanics of human achievement.
Soc Personal Psychol Compass. 2015;9:359–369.
3. Kanfer R, Frese M, Johnson RE. Motivation related to work: a century of progress. J
Appl Psychol. 2017;102:338.
Glutamine-to-glutamate ratio in the nucleus accumbens predicts. . .
A Strasser et al.
2055
Neuropsychopharmacology (2020) 45:2048 – 2057
4. Epstein J, Silbersweig D. The neuropsychiatric spectrum of motivational disorders.
J Neuropsychiatry Clin Neurosci. 2015;27:7–18.
5. Admon R, Pizzagalli DA. Corticostriatal pathways contribute to the natural time
course of positive mood. Nat Commun. 2015;6:10065.
6. Zald DH, Treadway MT. Reward processing, neuroeconomics, and psycho-
pathology. Annu Rev Clin Psychol. 2017;13:471–495.
7. Pessiglione M, Vinckier F, Bouret S, Daunizeau J, Le Bouc R. Why not try harder?
Computational approach to motivation deficits in neuro-psychiatric diseases.
Brain 2017;141:629–650.
8. Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus
accumbens dopamine and associated forebrain circuits. Psychopharmacology
2007;191:461–482.
9. Floresco SB. The nucleus accumbens: an interface between cognition, emotion,
and action. Annu Rev Psychol. 2015;66:25–52.
10. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing
monetary reward selectively recruits nucleus accumbens. J Neurosci. 2001;21:
RC159.
11. Pessiglione M, Schmidt L, Draganski B, Kalisch R, Lau H, Dolan RJ, et al. How the
brain translates money into force: a neuroimaging study of subliminal motiva-
tion. Science 2007;316:904–906.
12. Croxson PL, Walton ME, O’Reilly JX, Behrens TEJ, Rushworth MFS. Effort-based
cost-benefit valuation and the human brain. J Neurosci Off. J Neurosci.
2009;29:4531–4541.
13. Schmidt L, Lebreton M, Cléry-Melin M-L, Daunizeau J, Pessiglione M. Neural
mechanisms underlying motivation of mental versus physical effort. PLoS Biol.
2012;10:e1001266.
14. Hauser TU, Eldar E, Dolan RJ. Separate mesocortical and mesolimbic pathways
encode effort and reward learning signals. Proc Natl Acad Sci USA. 2017;114:
E7395–E7404.
15. Jocham G, Hunt LT, Near J, Behrens TEJ. A mechanism for value-guided choice
based on the excitation-inhibition balance in prefrontal cortex. Nat Neurosci.
2012;15:960–961.
16. Hu Y, Chen X, Gu H, Yang Y. Resting-state glutamate and GABA concentrations
predict task-induced deactivation in the default mode network. J Neurosci Off. J
Soc Neurosci. 2013;33:18566–18573.
17. Yoon JH, Grandelis A, Maddock RJ. Dorsolateral prefrontal cortex GABA con-
centration in humans predicts working memory load processing capacity. J
Neurosci. 2016;36:11788–11794.
18. Scholl J, Kolling N, Nelissen N, Stagg CJ, Harmer CJ, Rushworth MF. Excitation and
inhibition in anterior cingulate predict use of past experiences. ELife. 2017;6:
e20365. https://doi.org/10.7554/eLife.20365.
19. Walls AB, Waagepetersen HS, Bak LK, Schousboe A, Sonnewald U. The glutamine-
glutamate/GABA cycle: function, regional differences in glutamate and GABA
production and effects of interference with GABA metabolism. Neurochem Res.
2015;40:402–409.
20. Albrecht J, Sidoryk-Węgrzynowicz M, Zielińska M, Aschner M. Roles of glutamine
in neurotransmission. Neuron Glia Biol. 2010;6:263–276.
21. Berchio C, Rodrigues J, Strasser A, Michel CM, Sandi C. Trait anxiety on effort
allocation to monetary incentives: a behavioral and high-density EEG study.
Transl Psychiatry. 2019;9:174. https://doi.org/10.1038/s41398-019-0508-4.
22. Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M. Activational and
effort-related aspects of motivation: neural mechanisms and implications for
psychopathology. Brain. J Neurol 2016;139:1325–1347.
23. Covington MV. Goal theory, motivation, and school achievement: an integrative
review. Annu Rev Psychol. 2000;51:171–200.
24. Gilman JM, Treadway MT, Curran MT, Calderon V, Evins AE. Effect of social
influence on effort-allocation for monetary rewards. PLoS ONE 2015;10:e0126656.
25. Stanne MB, Johnson DW, Johnson RT. Does competition enhance or inhibit motor
performance: a meta-analysis. Psychol Bull. 1999;125:133.
26. Cooke A, Kavussanu M, McIntyre D, Ring C. Effects of competition on endurance
performance and the underlying psychological and physiological mechanisms.
Biol Psychol. 2011;86:370–378.
27. Le Bouc R, Pessiglione M. Imaging social motivation: distinct brain mechanisms
drive effort production during collaboration versus competition. J Neurosci.
2013;33:15894–15902.
28. Kilduff GJ. Driven to win: rivalry, motivation, and performance. Soc Psychol Per-
sonal Sci. 2014;5:944–952.
29. Luksys G, Fastenrath M, Coynel D, Freytag V, Gschwind L, Heck A, et al. Com-
putational dissection of human episodic memory reveals mental process-specific
genetic profiles. Proc Natl Acad Sci USA. 2015;112:E4939–E4948.
30. Luksys G, Gerstner W, Sandi C. Stress, genotype and norepinephrine in the
prediction of mouse behavior using reinforcement learning. Nat Neurosci.
2009;12:1180–1186.
31. Nassar MR, Frank MJ. Taming the beast: extracting generalizable knowledge from
computational models of cognition. Curr Opin Behav Sci. 2016;11:49–54.
32. Corrado G, Doya K. Understanding neural coding through the model-based
analysis of decision making. J Neurosci. 2007;27:8178–8180.
33. Strasser A, Xin L, Gruetter R, Sandi C. Nucleus accumbens neurochemistry in
human anxiety: a 7 T 1H-MRS study. Eur Neuropsychopharmacol.
2019;29:365–375.
34. Neto LL, Oliveira E, Correia F, Ferreira AG. The human nucleus accumbens: where
is it? A stereotactic, anatomical and magnetic resonance imaging study. Neuro-
modul Technol Neural Interface 2008;11:13–22.
35. Baujard A. Welfare Economics. Rochester. NY: Social Science Research Network;
2013.
36. Le Bouc R, Rigoux L, Schmidt L, Degos B, Welter M-L, Vidailhet M, et al. Com-
putational dissection of dopamine motor and motivational functions in humans.
J Neurosci. 2016;36:6623–6633.
37. Blasche G, Szabo B, Wagner‐Menghin M, Ekmekcioglu C, Gollner E. Comparison of
rest-break interventions during a mentally demanding task. Stress Health
2018;34:629–638.
38. Goette L, Bendahan S, Thoresen J, Hollis F, Sandi C. Stress pulls us apart: anxiety
leads to differences in competitive confidence under stress. Psychoneur-
oendocrinology 2015;54:115–123.
39. Schousboe A. Metabolic signaling in the brain and the role of astrocytes in
control of glutamate and GABA neurotransmission. Neurosci Lett.
2019;689:11–13.
40. Perea G, Navarrete M, Araque A. Tripartite synapses: astrocytes process and
control synaptic information. Trends Neurosci. 2009;32:421–431.
41. Rothman DL, Hyder F, Sibson N, Behar KL, Mason GF, Petroff OA, et al. In vivo
magnetic resonance spectroscopy studies of the glutamate and GABA neuro-
transmitter cycles and functional neuroenergetics. Philos Trans R Soc Lond B Biol
Sci. 1999;354:1165–1177.
42. Frank MJ, Moustafa AA, Haughey HM, Curran T, Hutchison KE. Genetic triple
dissociation reveals multiple roles for dopamine in reinforcement learning. Proc
Natl Acad Sci USA. 2007;104:16311–16316.
43. Schweighofer N, Bertin M, Shishida K, Okamoto Y, Tanaka SC, Yamawaki S, et al.
Low-serotonin levels increase delayed reward discounting in humans. J Neurosci.
2008;28:4528–4532.
44. Rappeneau V, Blaker A, Petro JR, Yamamoto BK, Shimamoto A. Disruption of the
glutamate-glutamine cycle involving astrocytes in an animal model of depression
for males and females. Front Behav Neurosci. 2016;10:231.
45. Set E, Saez I, Zhu L, Houser DE, Myung N, Zhong S, et al. Dissociable contribution
of prefrontal and striatal dopaminergic genes to learning in economic games.
Proc Natl Acad Sci USA. 2014;111:9615–9620.
46. Hsu M, Bhatt M, Adolphs R, Tranel D, Camerer CF. Neural systems responding to
degrees of uncertainty in human decision-making. Science 2005;310:1680–1683.
47. Blain B, Schmit C, Aubry A, Hausswirth C, Le Meur Y, Pessiglione M. Neuro-
computational impact of physical training overload on economic decision-
making. Curr Biol. 2019;29:3289–3297.
48. Kardos J, Dobolyi Á, Szabó Z, Simon Á, Lourmet G, Palkovits M, et al. Molecular
plasticity of the nucleus accumbens revisited—astrocytic waves shall rise. Mol
Neurobiol. 2019. https://doi.org/10.1007/s12035-019-1641-z.
49. Britt JP, Benaliouad F, McDevitt RA, Stuber GD, Wise RA, Bonci A. Synaptic and
behavioral profile of multiple glutamatergic inputs to the nucleus accumbens.
Neuron 2012;76:790–803.
50. Bernstein H-G, Meyer-Lotz G, Dobrowolny H, Bannier J, Steiner J, Walter M, et al.
Reduced density of glutamine synthetase immunoreactive astrocytes in different
cortical areas in major depression but not in bipolar I disorder. Front Cell Neu-
rosci. 2015;9:273.
51. Xin W, Mironova YA, Shen H, Marino RAM, Waisman A, Lamers WH, et al. Oli-
godendrocytes support neuronal glutamatergic transmission via expression of
glutamine synthetase. Cell Rep. 2019;27:2262–2271.
52. Mazat J-P, Ransac S. The fate of glutamine in human metabolism. the interplay
with glucose in proliferating cells. Metabolites 2019;9:81.
53. McKenna MC. The glutamate-glutamine cycle is not stoichiometric: fates of
glutamate in brain. J Neurosci Res. 2007;85:3347–3358.
54. Rangaraju V, Calloway N, Ryan TA. Activity-driven local ATP synthesis is required
for synaptic function. Cell 2014;156:825–835.
55. Tani H, Dulla CG, Farzampour Z, Taylor-Weiner A, Huguenard JR, Reimer RJ. A
local glutamate-glutamine cycle sustains synaptic excitatory transmitter release.
Neuron 2014;81:888–900.
56. Haber SN, Behrens TE. The neural network underlying incentive-based learning:
implications for interpreting circuit disruptions in psychiatric disorders. Neuron
2014;83:1019–1039.
57. Otis JM, Namboodiri VM, Matan AM, Voets ES, Mohorn EP, Kosyk O, et al. Pre-
frontal cortex output circuits guide reward seeking through divergent cue
encoding. Nature 2017;543:103.
58. Hailwood JM, Gilmour G, Robbins TW, Saksida LM, Bussey TJ, Marston HM, et al.
Oxygen responses within the nucleus accumbens are associated
Glutamine-to-glutamate ratio in the nucleus accumbens predicts. . .
A Strasser et al.
2056
Neuropsychopharmacology (2020) 45:2048 – 2057
with individual differences in effort exertion in rats. Eur J Neurosci.
2018;48:2971–2987.
59. Hollis F, Kooij MA, van der, Zanoletti O, Lozano L, Cantó C, Sandi C. Mitochondrial
function in the brain links anxiety with social subordination. Proc Natl Acad Sci.
2015;112:15486–15491.
60. van der Kooij MA, Zalachoras I, Sandi C. GABAA receptors in the ventral teg-
mental area control the outcome of a social competition in rats. Neuropharma-
cology 2018;138:275–281.
61. Marcora SM, Staiano W. The limit to exercise tolerance in humans: mind over
muscle? Eur J Appl Physiol. 2010;109:763–770.
62. Massar SAA, Csathó Á, Van der Linden D. Quantifying the motivational effects of
cognitive fatigue through effort-based decision making. Front Psychol.
2018;9:843. https://doi.org/10.3389/fpsyg.2018.00843.
63. Inzlicht M, Marcora SM. The central governor model of exercise regulation tea-
ches us precious little about the nature of mental fatigue and self-control failure.
Front Psychol. 2016;7:656.
64. Armstrong CW, McGregor NR, Sheedy JR, Buttfield I, Butt HL, Gooley PR. NMR
metabolic profiling of serum identifies amino acid disturbances in chronic fatigue
syndrome. Clin Chim Acta. 2012;413:1525–1531.
65. Wilkinson DJ, Smeeton NJ, Watt PW. Ammonia metabolism, the brain and fatigue;
revisiting the link. Prog Neurobiol. 2010;91:200–219.
66. Coqueiro AY, Raizel R, Bonvini A, Hypólito T, Godois A da M, Pereira JRR, et al.
Effects of glutamine and alanine supplementation on central fatigue markers in
rats submitted to resistance training. Nutrients. 2018;10:119. https://doi.org/
10.3390/nu10020119.
67. Nava RC, Zuhl MN, Moriarty TA, Amorim FT, Bourbeau KC, Welch AM, et al. The
effect of acute glutamine supplementation on markers of inflammation and
fatigue during consecutive days of simulated wildland firefighting. J Occup
Environ Med. 2019;61:e33–e42.
68. Wang L, Maher TJ, Wurtman RJ. Oral L-glutamine increases GABA levels in striatal
tissue and extracellular fluid. FASEB J. 2007;21:1227–1232.
69. Nestler EJ, Carlezon WA. The mesolimbic dopamine reward circuit in depression.
Biol Psychiatry 2006;59:1151–1159.
70. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, et al. Global
brain gene expression analysis links glutamatergic and GABAergic alterations to
suicide and major depression. PloS ONE 2009;4:e6585.
71. Öngür D, Haddad S, Prescot AP, Jensen JE, Siburian R, Cohen BM, et al.
Relationship between genetic variation in the glutaminase gene GLS1 and
brain glutamine/glutamate ratio measured in vivo. Biol Psychiatry
2011;70:169–174.
72. Larrieu T, Cherix A, Duque A, Rodrigues J, Lei H, Gruetter R, et al. Hierarchical
status predicts behavioral vulnerability and nucleus accumbens metabolic profile
following chronic social defeat stress. Curr Biol. 2017;27:2202–2210.
73. Cherix A, Larrieu T, Grosse J, Rodrigues J, McEwen B, Nasca C, et al. Metabolic
signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-
carnitine. Elife 2020;9:e50631.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in anymedium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2020
Glutamine-to-glutamate ratio in the nucleus accumbens predicts. . .
A Strasser et al.
2057
Neuropsychopharmacology (2020) 45:2048 – 2057
